ActiPatch Plantar Fasciitis Clinical Trial

University of British Columbia28 enrolled

Overview

Plantar fasciopathy is a chronic condition affecting both sedentary populations, individuals in the workplace who must stand for prolonged periods of time, and athletes. It can be disabling. There is no single accepted treatment course that is recommended in the literature. The use of pulsed radio-frequency electromagnetic (PRFE) devices has been proposed as a treatment option in chronic soft-tissue injury due to its ability to reduce pain and inflammation. The proposed study will investigate the efficacy of the use of a PRFE device for the treatment of chronic heel pain using a double blind randomized placebo controlled design study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Plantar Fasciitis Plantar Fasciopathy

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with diagnosis of plantar fasciitis agreeing to participate * Over 18 years old * Able to wear unit and keep data up-to-date records of use * Agree to forgo additional treatments during the study period Exclusion Criteria: * Patients who have refused, are unable to give or have withdrawn consent * Patients with heel pain present less than 3 months

Outcomes

Primary Outcomes

Visual Analog Scale (VAS) for pain

Time frame: 4 Weeks Follow-up

Secondary Outcomes

Visual analog scale for pain

Time frame: 26 weeks

Foot and ankle disability index

Time frame: 26 weeks

Tegner activity scale

Time frame: 26 weeks

ActiPatch Plantar Fasciitis Clinical Trial

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes